Coxsackie- and adenovirus receptor (CAR) is expressed in lymphatic vessels in human skin and affects lymphatic endothelial cell function in vitro
Authors:
- Claudia ZgraggenCZClaudia Zgraggen
- Nadia RehmanNRNadia Rehman
- Nadia E. Banziger-ToblerNBNadia E. Banziger-Tobler
- Michael DetmarMDMichael Detmar
- Cornelia HalinCHCornelia Halin
- 1 January 2009
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 315 (2) , 336-347
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (3100A0‑108207, CA69184, CA92644)
- Stiftung Professor Dr. Max Cloëtta
This publication has 46 references indexed in Scilit:
- Molecular Biology and Pathology of LymphangiogenesisAnnual Review of Pathology: Mechanisms of Disease, 2008
- New Insights into the Molecular Control of the Lymphatic Vascular System and its Role in DiseaseJournal of Investigative Dermatology, 2006
- Tumor and lymph node lymphangiogenesis—impact on cancer metastasisJournal of Leukocyte Biology, 2006
- AngiogenesisAnnual Review of Medicine, 2006
- Lymphangiogenesis in development and human diseaseNature, 2005
- CAR: A virus receptor within the tight junctionAdvanced Drug Delivery Reviews, 2005
- The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junctionProceedings of the National Academy of Sciences, 2001
- Prox1 Function Is Required for the Development of the Murine Lymphatic SystemCell, 1999
- LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for HyaluronanJournal of Cell Biology, 1999
- Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic CapillariesThe American Journal of Pathology, 1999